Selank Nasal Spray vs. Injection

Selank has primarily been investigated as a peptide administered intranasally, with the majority of published scientific literature focusing on nasal delivery rather than injection. The intranasal route of administration was intentionally chosen during the peptide's development because it may facilitate access to the central nervous system via the olfactory and trigeminal pathways. This allows Selank to potentially modulate brain function while bypassing significant systemic metabolism [1,2]. Studies evaluating Selank's effects on anxiety, neurochemistry, gene expression, and brain-derived neurotrophic factor (BDNF) regulation have predominantly utilized intranasal administration [2–5].

For comparison, very few clinical studies have been published regarding subcutaneous or intramuscular injections of Selank. Although injectable formulations are available from some peptide suppliers, there is currently insufficient clinical data to conclude that injections provide superior effects for anxiety reduction, cognitive enhancement, or other potential applications. Since most mechanistic and clinical research has been conducted using intranasal Selank, this route of administration currently has the strongest scientific basis [2–6].

Is Selank Better Used as a Nasal Spray or in Injection Form?

Currently, there are no high-quality studies directly comparing intranasal and injectable Selank in humans.

From an evidence-based medicine perspective, nasal administration offers several significant advantages. The majority of published clinical trials have utilized this route of administration, and animal studies demonstrating changes in BDNF expression and neurochemical regulation have also relied on nasal delivery. Additionally, it is a non-invasive method and was specifically developed for delivering peptides to the brain [2–5].

Injectable administration can theoretically lead to different pharmacokinetic properties and altered systemic exposure. However, potential differences have not been adequately investigated in controlled clinical trials. Consequently, there is currently no evidence to suggest that injections are more effective than nasal administration.

Comparison of Selank Nasal Spray and Injection

Scientific Conclusions

Based on currently available data, intranasal Selank is the best-studied route of administration and remains the most commonly used form.

Stability of Selank and Shelf Life

Selank is a synthetic heptapeptide (Thr-Lys-Pro-Arg-Pro-Gly-Pro) composed of amino acids that can gradually degrade under unfavorable environmental conditions, such as high temperature, humidity, multiple freeze-thaw cycles, and prolonged storage in solution [7].

Like many other peptides, the stability of Selank primarily depends on temperature, storage conditions, light exposure, the.

Does Selank require refrigeration?

Unreconstituted Freeze-Dried Powder

Freeze-dried peptide powder is generally more stable than peptides stored in solution. Manufacturers often recommend storing unopened peptide vials at 2–8°C, away from light, and in a dry environment.

Some freeze-dried peptides may remain stable for extended periods when stored in the refrigerator; however, precise data on the stability of Selank are still limited.

Dissolved Selank

Upon dissolution with bacteriostatic water or another solvent, peptide degradation may accelerate. Therefore, it is recommended to store at 2–8°C, avoid excessive heat, limit temperature fluctuations, and avoid multiple freeze-thaw cycles.

How long can you store dissolved Selank?

Currently, no stability studies have been published that determine the exact shelf life of dissolved Selank.

Since peptides in solution may degrade over time, peptide laboratories often recommend using dissolved preparations within a few weeks while storing them in the refrigerator. However, these recommendations are based primarily on general guidelines for handling peptides, rather than on direct stability studies conducted specifically for Selank.

Therefore, it is currently not possible to determine a specific expiration date with full confidence based on available scientific evidence.

Scientific Conclusions

Selank appears to follow the typical stability rules for therapeutic peptides. Refrigeration is generally recommended after reconstitution, however, the exact stability period of reconstituted Selank has not been determined in published clinical studies.

Selank in Powder, Nasal Spray, and Vials

Selank is most commonly available in three basic forms: lyophilized powder, vials with peptide, and nasal spray preparations.

Selank Powder

Selank in powder form typically refers to the peptide in a lyophilized (freeze-dried) state. The freeze-drying process removes water and improves stability during storage and transport. The powder itself is not used directly and usually requires reconstitution before use.

Freeze-dried peptides are widely used because dry preparations usually retain greater stability than peptides stored in solution.

Vials of Selank

The term „Selank vial” most commonly refers to containers holding lyophilized powder requiring reconstitution or ready-to-use liquid preparations.

The concentration and purpose of the product depend on the manufacturer and the specific formulation. Published scientific studies usually describe the peptide itself, not specific commercial products.

Selank Nasal Spray

Nasal spray with Selank is the best-studied form in scientific literature. Numerous studies concerning anxiety, neurochemical modulation, gene expression, and neurotrophic activity have utilized nasal administration [2–5].

Nasal administration is particularly interesting because peptides delivered via the nasal cavity can partially bypass degradation in the gastrointestinal tract and potentially gain access to the central nervous system through olfactory pathways.

Scientific Conclusions

Of the currently available forms, intranasally administered Selank has the strongest scientific basis, while powder and vials are primarily pharmaceutical forms used for preparing the peptide for administration.

What forms of Selank are available

Selank is offered and discussed in several different forms, although not all have been extensively scientifically studied.

Selank Nasal Spray

Nasal Selank is the best-studied form and has been used in both human and animal studies concerning anxiety disorders, cognitive function, neurotransmitter modulation, BDNF expression, and stress response [2–6].

Selank for Injection

Injectable preparations are commercially available; however, published data regarding their efficacy, pharmacokinetics, and safety are very limited compared to nasal administration.

Selank Drops

Terms Selank drops i Selank nasal drops They are sometimes used interchangeably with nasal sprays. Both methods involve the intranasal administration of dissolved peptide preparations.

Selank tablets

Currently, there are very few scientific publications on Selank oral tablets. Since peptides are generally susceptible to degradation in the gastrointestinal tract, oral administration poses significant formulation challenges.

Scientific Conclusions

Most studies confirming the potential neurobiological effects of Selank have been conducted using intranasal administration, which is why this form of administration currently has the strongest support in scientific literature.

Disclaimer

The content is for educational and informational purposes only and does not constitute medical advice, diagnosis, therapy, or recommendations for use. Selank has not been approved by the US Food and Drug Administration (FDA) or the European Medicines Agency (EMA) for the treatment of anxiety disorders, cognitive disorders, or any other medical conditions. Most available data comes from preclinical studies and limited human trials, many of which used intranasal administration. Information on storage, stability, and alternative forms of the preparation is for educational purposes only and should not be interpreted as official recommendations for use.

References

[1] PubChem. (2026). Selank (CID: 11765600). National Center for Biotechnology Information. https://pubchem.ncbi.nlm.nih.gov/compound/Selank

[2] Levitskaya, N. G., Andreeva, L. A., Mezentseva, M. V., Shapoval, I. M., Podchernyaeva, R. Y., Shcherbenko, V. E., Potapova, L. A., Russu, L. I., Ershov, F. I., & Myasoedov, N. F. (2010). Intranasal administration of the peptide Selank regulates BDNF expression in the rat hippocampus in vivo. Doklady Biological Sciences, 431, 79–82.

[3] Vyunova, T. V., Andreeva, L., Shevchenko, K., & Myasoedov, N. F. (2018). Peptide-based anxiolytics: The molecular aspects of heptapeptide Selank biological activity. Protein and Peptide Letters, 25(10), 914-923. https://doi.org/10.2174/0929866525666180925144642

[4] Zozulia, A. A., Neznamov, G. G., Siuniakov, T. S., Kost, N. V., Gabaeva, M. V., Sokol. Journal of Neurology and Psychiatry named after S.S. Korsakov, 108(4), 38-48. https://pubmed.ncbi.nlm.nih.gov/18454096/

[5] Andreeva, L. A., Nagaev, I. Y., Mezentseva, M. V., Shapoval, I. M., Podchernyaeva, R. Y., Shcherbenko, V. E., Potapova, L. A., Russu, L. I., Ershov, F. I., & Myasoedov, N. F. (2010). Antiviral properties of structural fragments of the peptide Selank. Doklady Biological Sciences, 431, 79–82. https://doi.org/10.1134/S0012496610020031

[6] Zozulya, A. A., Kost, N. V., Sokolov, O. Y., Gabaeva, M. V., Grivennikov, I. A., Andreeva, L. N., Zolotarev, Y. A., Ivanov, S. V., Andryushchenko, A. V., Myasoedov, N. F., & Smulevich, A. B. (2001). The inhibitory effect of Selank on enkephalin-degrading enzymes as a possible mechanism of its anxiolytic activity. Bulletin of Experimental Biology and Medicine, 131, 315–317. https://doi.org/10.1023/A:1017979514274

[7] PubChem. (2026). Selank: Chemical and Physical Properties. National Library of Medicine. https://pubchem.ncbi.nlm.nih.gov/compound/Selank